Latest news with #MaxHealthcareInstitute
Mint
16-07-2025
- Business
- Mint
Asian Paints, Mazagon Dock, CDSL to BSE: Top stocks that mutual funds bought and sold in June
Indian mutual funds continued their buying streak in June 2025, deploying a net ₹ 154 billion into equity markets (both primary and secondary), as per data from Nuvama Alternative & Quantitative Research. The allocation was accompanied by foreign institutional investors (FIIs) who pumped in ₹ 167 billion, marking strong capital flows into Indian equities. Mutual fund holdings in cash and equivalents dropped to ₹ 1,807 billion or 5.34% of assets under management (AUM), down from ₹ 1,961 billion (6.05%) in May — reflecting increased conviction in equity markets despite global volatility. Within pure equity mutual fund schemes, the large-cap space saw selective churn. Top largecap stocks that mutual funds bought in June included Asian Paints, Trent, Bajaj Finserv, Infosys, and Bharti Airtel, indicating a tilt towards quality consumption and financial names. On the flip side, fund managers trimmed positions in heavyweights such as Tata Consultancy Services (TCS), DLF, Jindal Steel & Power, Kotak Mahindra Bank, and Coal India. Mid-cap activity was more dynamic. The mid-cap stocks that mutual funds bought the most were Dixon Technologies, Biocon, Aditya Birla Capital, Container Corporation, and Star Health Insurance. Top midcap stocks sold included Indian Hotels Company, Mazagon Dock Shipbuilders, Solar Industries, Coforge, and Max Healthcare Institute, Nuvama report showed. Notably, New India Assurance shares made its way into portfolios as a fresh entry. In the small-cap space, fund managers were aggressive buyers in smallcap stocks such as Kaynes Technology India, Zydus Wellness, Capri Global Capital, Aptus Value Housing, and Jubilant Ingrevia. The segment also saw new entries in Capri Global and Suven Life Sciences shares. However, prominent names like BSE, CDSL, Hitachi Energy India, Computer Age Management Services (CAMS), and Motilal Oswal Financial Services were the top smallcap stocks that mutual funds sold the most in June, according to Nuvama report. PSP Projects and Uniparts India were completely exited during the month. Over the past three months, mutual funds steadily added large-cap stocks such as Reliance Industries, HDFC Bank, TCS, Titan Company, and ONGC shares, while trimming stakes in Bharat Electronics (BEL), BPCL, TVS Motor Company, Godrej Consumer Products, and Max Healthcare Institute, the Nuvama report showed. Among mid-cap stocks, top recurring additions were Kaynes Technology India, Dalmia Bharat, KPIT Technologies, Multi Commodity Exchange of India (MCX), and NBCC India. Funds pared positions in Gujarat Fluorochemicals, CRISIL, Narayana Hrudayalaya, ACC, and Cholamandalam Finance. Key additions among the small-cap stocks included Alkyl Amines Chemicals, Alok Industries, KPI Green Energy, Kirloskar Ferrous, and Gabriel India, while reductions were noted in Vijaya Diagnostic, India Shelter Finance, Happy Forgings, Sansera Engineering, and Galaxy Surfactants. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
&w=3840&q=100)
Business Standard
03-07-2025
- Business
- Business Standard
Max, Aster DM, Apollo rally up to 7%; what's driving hospital stocks today?
Hospital stocks in focus: Shares of the listed companies engaged in hospital business like Max Healthcare Institute, Aster DM Healthcare and Apollo Hospitals Enterprise have rallied up to 7 per cent, hitting their respective new highs on the BSE in Thursday's intra-day trade on healthy business outlook. Among the individual stocks, Aster DM Healthcare has surged 7 per cent to ₹638.60, on the back of a 20-fold jump in average trading volumes. A combined 16.06 million equity shares representing 3.2 per cent of total equity of the company have changed hands on the NSE and BSE. Shares of Apollo Hospitals Enterprise (₹7,599.75) and Max Healthcare Institute (₹1,308.55) were up 2 per cent on the BSE. Besides these three stocks, Global Health, Fortis Healthcare, Fortis Malar Hospitals, Narayana Hrudayalaya and Yatharth Hospital & Trauma Care Services were up in the range of 1 per cent to 3 per cent. In comparison, the BSE Sensex was up 0.18 per cent at 83,562 at 02:07 PM. What's driving hospital stocks? According to CRISIL MI&A Research, the Indian healthcare delivery industry is projected to experience major growth, with a compound annual growth rate (CAGR) of 9-11 per cent anticipated between fiscal years 2025 and 2027. This growth trajectory is underpinned by several long term structural factors, including rising healthcare needs due to demographic shifts and increasing chronic disease prevalence. Additionally, the industry's strong fundamentals, coupled with improving affordability among the population, are expected to drive demand for healthcare services. Furthermore, the potential impact of initiatives such as the Ayushman Bharat scheme, aimed at providing universal health coverage, is poised to further propel industry growth during this period. With sustained support from long-term structural factors, renewed emphasis on the Pradhan Mantri Jan Arogya Yojana (PMJAY), and heightened Government focus on the healthcare sector, the healthcare delivery market is projected to expand at a CAGR of approximately 9-11 per cent, reaching ₹8.6 trillion by fiscal 2027, Apollo Hospital said in its annual report. Given the major mismatch between demand and supply for quality beds, along with the improved financial health of corporate hospitals following the pandemic, players appear well-positioned to achieve profitable growth as they strengthen their presence in core markets and venture into Tier 2+ areas geographies, CareEdge Ratings said. CareEdge Ratings forecasts that the corporate hospital chains in its coverage will achieve approximately 10-12 per cent year-on-year sales growth in fiscal 2026, driven by a 5-6 per cent increase in Average Revenue Per Occupied Bed (ARPOB), a 100-200 basis point (bps) improvement in occupancy, and rise in new bed additions. With significant untapped market opportunities and a shortage of healthcare infrastructure in India, leading Indian companies have immense potential for expansion. Supported by long-term structural growth factors, renewed momentum from PMJAY, and increased government focus on the healthcare sector, the Indian hospital sector is projected to grow at a CAGR of 10-11 per cent over the next 3-5 years. Key demand drivers include the rise in lifestyle-related diseases, growing medical tourism, increasing incomes, and demographic changes. With limited government capital expenditure and a lack of infrastructure, the private sector is expected to experience accelerated growth in the years to come, CareEdge Ratings said in its March 2025 report.
Economic Times
17-06-2025
- Business
- Economic Times
Tanla Platforms shares rally 8% as board approves Rs 175-crore share buyback at Rs 875 apiece
Tanla Platforms shares rallied 7.8% to their day's high of Rs 708 on the BSE on Tuesday after the company announced that its board has approved a share buyback proposal worth up to Rs 175 crore. ADVERTISEMENT The company plans to repurchase up to 20 lakh fully paid-up equity shares, representing approximately 1.49% of its total equity capital, at a price of Rs 875 per share through the tender offer route. The buyback offer constitutes 24.81% and 7.78% of the company's paid-up equity share capital and free reserves based on its latest standalone and consolidated financial statements as of March 31, 2025, respectively. Also Read: Technical picks: Max Healthcare Institute, 360 ONE among 6 stocks that can rally up to 14% in near termThe buyback will be executed on a proportionate basis for all eligible shareholders and beneficial owners as on the record date, which will be announced later. The company will conduct the process through remote electronic voting and postal ballot to secure shareholder approval via a special resolution. Also Read:10 midcap stocks with more than 20 buy Calls: Analysts see up to 25% upside ADVERTISEMENT In the March 2025 quarter, Tanla Platforms reported a 9.9% year-on-year decline in net profit to Rs 117.3 crore, compared with Rs 130.2 crore a year ago. Revenue rose slightly by 1.9% to Rs 1,024.4 crore, while EBITDA increased by the same margin to Rs 163.4 crore. ADVERTISEMENT The EBITDA margin remained steady at 16%, indicating no material gain in operational efficiency despite the modest rise in revenue. Also Read: These 11 Nifty microcap stocks can rally 55-210% in the next 12 months ADVERTISEMENT According to Trendlyne, the average target price for Tanla Platforms stands at Rs 608, implying a potential downside of around 8% from current levels. Among the three analysts tracking the stock, the consensus rating is 'Buy'. Technical indicators show the stock's Relative Strength Index (RSI) at 67.9 — nearing overbought territory. The MACD stands at 31.6 and remains above its centerline and signal line, which is considered a bullish signal. Tanla Platforms shares closed 1.3% lower at Rs 656.9 on the BSE in the previous session. The stock has surged 53% over the past three months but is still down over 32% in the past year. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
17-06-2025
- Business
- Time of India
Tanla Platforms shares in focus as board approves Rs 175-crore share buyback at Rs 875 apiece
Tanla Platforms shares will be in focus on Tuesday after the company announced that its board has approved a share buyback proposal worth up to Rs 175 crore. The company plans to repurchase up to 20 lakh fully paid-up equity shares , representing approximately 1.49% of its total equity capital, at a price of Rs 875 per share through the tender offer route. The buyback offer constitutes 24.81% and 7.78% of the company's paid-up equity share capital and free reserves based on its latest standalone and consolidated financial statements as of March 31, 2025, respectively. Also Read: Technical picks: Max Healthcare Institute, 360 ONE among 6 stocks that can rally up to 14% in near term The buyback will be executed on a proportionate basis for all eligible shareholders and beneficial owners as on the record date, which will be announced later. The company will conduct the process through remote electronic voting and postal ballot to secure shareholder approval via a special resolution. Also Read: 10 midcap stocks with more than 20 buy Calls: Analysts see up to 25% upside Tanla Platforms Q4 earning In the March 2025 quarter, Tanla Platforms reported a 9.9% year-on-year decline in net profit to Rs 117.3 crore, compared with Rs 130.2 crore a year ago. Revenue rose slightly by 1.9% to Rs 1,024.4 crore, while EBITDA increased by the same margin to Rs 163.4 crore. The EBITDA margin remained steady at 16%, indicating no material gain in operational efficiency despite the modest rise in revenue. Also Read: These 11 Nifty microcap stocks can rally 55-210% in the next 12 months Tanla Platforms share price target According to Trendlyne, the average target price for Tanla Platforms stands at Rs 608, implying a potential downside of around 8% from current levels. Among the three analysts tracking the stock, the consensus rating is 'Buy'. Technical indicators show the stock's Relative Strength Index (RSI) at 67.9 — nearing overbought territory. The MACD stands at 31.6 and remains above its centerline and signal line, which is considered a bullish signal. Tanla Platforms shares closed 1.3% lower at Rs 656.9 on the BSE in the previous session. The stock has surged 53% over the past three months but is still down over 32% in the past year. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Business Upturn
16-06-2025
- Business
- Business Upturn
Stocks hitting 52-week highs today, June 16: Bharat Electronics, Laurus Labs, Max Healthcare, JK Cement and more
Indian equity markets closed on a positive note on June 16, 2025, as benchmark indices posted strong gains across the board. The BSE Sensex surged 677.55 points (0.84%) to close at 81,796.15, while the NSE Nifty 50 climbed 227.90 points (0.92%) to settle at 24,946.50, just shy of the key 25,000 mark. Amid this rally, several stocks hit fresh 52-week highs, signalling strong investor interest. Stocks That Hit 52-Week Highs Today Company Market Price (₹) Change (%) 52-Week High (₹) Bharat Electronics 403.85 2.45% 404.50 Max Healthcare Institute 1,246.80 1.14% 1,250.00 Laurus Labs 680.25 2.05% 683.00 Muthoot Finance 2,633.30 1.33% 2,645.20 Max Financial Services 1,577.00 3.34% 1,586.80 Fiem Industries 1,944.50 2.76% 1,960.00 Force Motors 13,961.00 4.57% 14,100.00 Subros 987.90 18.81% 997.80 Strides Pharma Science 891.90 1.07% 901.05 Ramco Cements 1,070.85 0.78% 1,082.50 Narayana Hrudayalaya 1,934.10 1.10% 1,957.00 Maharashtra Scooters 15,135.00 4.27% 15,326.00 Nazara Technologies 1,332.10 0.32% 1,354.00 Shilpa Medicare 983.55 -0.23% 1,000.00 Karur Vysya Bank 248.55 0.31% 253.50 Manappuram Finance 278.81 -0.26% 284.90 JK Cement 5,978.50 -1.71% 6,145.00 Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Bharat ElectronicsJK CementLaurus LabsMax HealthcareStock Market Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
